earnings Archives | Page 36 of 77 | Be Korea-savvy
POSCO’s Q3 Operating Income at Record High on Robust Demand

POSCO’s Q3 Operating Income at Record High on Robust Demand

SEOUL, Oct. 13 (Korea Bizwire) — POSCO, the world’s fifth-largest steelmaker by output, said Wednesday its third-quarter operating income more than quadrupled to a record high on robust demand amid the global economic recovery from the COVID-19 pandemic. Operating income for the three months that ended in September reached 3.11 trillion won (US$2.6 billion) on [...]

Constellation Brands Reports Second Quarter Fiscal 2022 Results

Constellation Brands Reports Second Quarter Fiscal 2022 Results

VICTOR, N.Y., Oct. 6 (Korea Bizwire) – Constellation Brands, Inc. (NYSE: STZ and STZ.B), a leading beverage alcohol company, reported today its second quarter fiscal 2022 results. A conference call to discuss the financial results and outlook will be hosted by President and Chief Executive Officer Bill Newlands and Chief Financial Officer Garth Hankinson on Wednesday, [...]

Financial Firms’ Overseas Units Shine in H1 Despite Pandemic

Financial Firms’ Overseas Units Shine in H1 Despite Pandemic

SEOUL, Oct. 6 (Korea Bizwire) — South Korean financial companies’ overseas units saw their earnings jump more than 27 percent in the first half of the year despite the coronavirus pandemic, a corporate tracker said Wednesday. According to CEO Score, 222 overseas subsidiaries of major banks and other financial institutions posted a combined net income [...]

AGF Management Limited Reports Third Quarter 2021 Financial Results

AGF Management Limited Reports Third Quarter 2021 Financial Results

TORONTO, Sept. 29 (Korea Bizwire) – Reported diluted earnings per share of $0.21 Mutual fund gross sales of $790 million for the third quarter of 2021, an improvement of 61% year-over-year Mutual fund net sales of $288 million for the quarter Total assets under management and fee-earning assets1 of $43.4 billion AGF Management Limited (AGF or [...]

AKWEL: Net Earnings of €38 M in H1 2021

AKWEL: Net Earnings of €38 M in H1 2021

CHAMPFROMIER, France, Sept. 23 (Korea Bizwire) — AKWEL (FR0000053027, AKW, PEA-eligible), the automotive and HGV equipment and systems manufacturer specialising in fluid management and mechanisms, published its 2021 half-yearly results. Consolidated data – in € millions 30.06.2021 30.06.2020 Var. in % Revenue 487.6 387.0 +26.0% EBITDA 64.7 60.0 +7.9% Current operating income 50.0 24.3 +105.8% Current [...]

Adagio Therapeutics Provides COVID-19 Antibody Program Updates as well as Business Highlights and Second Quarter 2021 Financial Results

Adagio Therapeutics Provides COVID-19 Antibody Program Updates as well as Business Highlights and Second Quarter 2021 Financial Results

WALTHAM, Mass., Sept. 20 (Korea Bizwire) — Adagio Therapeutics, Inc., (Nasdaq: ADGI) a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of antibody-based solutions for infectious diseases with pandemic potential, today reported updates on its lead COVID-19 antibody program, ADG20, as well as recent business highlights and second quarter 2021 financial results. “Across [...]

Constellation Brands to Report Second Quarter Fiscal 2022 Financial Results; Host Conference Call October 6, 2021

Constellation Brands to Report Second Quarter Fiscal 2022 Financial Results; Host Conference Call October 6, 2021

VICTOR, N.Y., Sept. 2 (Korea Bizwire) – Constellation Brands, Inc. (NYSE: STZ and STZ.B), a leading beverage alcohol company, announced today it will report financial results for its fiscal second quarter ended August 31, 2021, on Wednesday, October 6, 2021, before the open of the U.S. markets. A conference call to discuss the financial results and outlook [...]

Nyxoah Issues First Half 2021 Financial Results

Nyxoah Issues First Half 2021 Financial Results

Mont-Saint-Guibert, Belgium, Aug. 31 (Korea Bizwire) – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)(“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced its unaudited condensed consolidated interim financial statements for the first half of 2021.   Highlights  $97.8 million Nasdaq IPO gross [...]